ArticleCost effectiveness and resource allocation : C/E2018

The early economic evaluation of novel biomarkers to accelerate their translation into clinical applications.

Gimon de Graaf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.